129 related articles for article (PubMed ID: 6121016)
1. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine.
Sagar SM; Landry D; Millard WJ; Badger TM; Arnold MA; Martin JB
J Neurosci; 1982 Feb; 2(2):225-31. PubMed ID: 6121016
[TBL] [Abstract][Full Text] [Related]
2. Depletion of striatal somatostatin by local cysteamine injection.
Beal MF; Martin JB
Brain Res; 1984 Aug; 308(2):319-24. PubMed ID: 6148124
[TBL] [Abstract][Full Text] [Related]
3. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus.
Kwok RP; Cameron JL; Faller DV; Fernstrom JD
Endocrinology; 1992 Dec; 131(6):2999-3009. PubMed ID: 1359964
[TBL] [Abstract][Full Text] [Related]
4. Cysteamine induces a loss of tissue somatostatin-28 when measured as somatostatin-28(15-28)-like immunoreactivity but not when assessed as somatostatin-28(1-14)-like immunoreactivity: evidence for the importance of the disulfide bond for cysteamine action.
Patel YC; Pierzchala I
Endocrinology; 1985 May; 116(5):1699-702. PubMed ID: 2859189
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.
McIntosh CH; Bakich V; Bokenfohr K; DiScala-Guenot D; Kwok YN; Brown JC
Regul Pept; 1988 Jun; 21(3-4):205-18. PubMed ID: 2901134
[TBL] [Abstract][Full Text] [Related]
6. Effect of cysteamine on somatostatin-like immunoreactivity in the amygdala-kindled rat brain.
Pitkänen A; Hyttinen JM; Riekkinen PJ
Neuropeptides; 1989 Jul; 14(1):11-6. PubMed ID: 2571106
[TBL] [Abstract][Full Text] [Related]
7. A critical evaluation of cysteamine as a tool to deplete somatostatin in the rat central nervous system.
Cook LL; Bissette G; Dole K; Nemeroff CB
Endocrinology; 1989 Feb; 124(2):855-61. PubMed ID: 2563244
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of cysteamine: relationship to somatostatin depletion.
Brown MR; Fisher LA; Sawchenko PE; Swanson LW; Vale WW
Regul Pept; 1983 Jan; 5(2):163-79. PubMed ID: 6131501
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of cysteamine on cognitive and locomotor behavior in rats: relationship to hippocampal glial pathology and somatostatin levels.
Justino L; Welner SA; Tannenbaum GS; Schipper HM
Brain Res; 1997 Jun; 761(1):127-34. PubMed ID: 9247075
[TBL] [Abstract][Full Text] [Related]
10. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.
Srikant CB; Patel YC
Endocrinology; 1984 Sep; 115(3):990-5. PubMed ID: 6146517
[TBL] [Abstract][Full Text] [Related]
11. Evidence for selective release of somatostatin-14 and somatostatin-28(1-12) from rat hypothalamus.
Bakhit C; Koda L; Benoit R; Morrison JH; Bloom FE
J Neurosci; 1984 Feb; 4(2):411-9. PubMed ID: 6142098
[TBL] [Abstract][Full Text] [Related]
12. Effects of cysteamine administration on the in vivo incorporation of [35S]cysteine into somatostatin-14, somatostatin-28, arginine vasopressin, and oxytocin in rat hypothalamus.
Cameron JL; Fernstrom JD
Endocrinology; 1986 Sep; 119(3):1292-7. PubMed ID: 2874017
[TBL] [Abstract][Full Text] [Related]
13. Cysteamine normalizes cerebral somatostatin level and binding in pentylenetetrazol-kindled rats.
Perez-Oso E; Lopez-Ruiz MP; Gonzalez-Guijarro L; Arilla E
Life Sci; 1989; 45(25):2451-8. PubMed ID: 2575202
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine-induced depletion of somatostatinergic systems alters potentials evoked from the rat visual cortex.
Fontanesi G; Siciliano R; Porciatti V; Bagnoli P
Vis Neurosci; 1996; 13(2):327-34. PubMed ID: 8737284
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine-induced depletion of somatostatin and prolactin.
Millard WJ; Sagar SM; Martin JB
Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
[TBL] [Abstract][Full Text] [Related]
16. Cysteamine can induce duodenal ulceration in rats without depletion of immunoreactive somatostatin.
Kapuscinski M; Shulkes A; Green M; Read D; MacLellan DG
Regul Pept; 1991 Nov; 36(3):391-406. PubMed ID: 1687422
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the effects of cysteamine on somatostatin-like immunoreactivity in the rat central nervous system.
Ceccatelli S; Hökfelt T; Hallman H; Nylander I; Terenius L; Elde R; Brownstein M
Peptides; 1987; 8(2):371-84. PubMed ID: 2884649
[TBL] [Abstract][Full Text] [Related]
18. The effect of cysteamine on immunoreactive somatostatin in the rabbit retina.
Sagar SM; Martin JB
Neurosci Lett; 1982 Dec; 34(3):265-9. PubMed ID: 6186951
[TBL] [Abstract][Full Text] [Related]
19. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-induced somatostatin release from perifused rat hypothalamus: calcium dependency and effect of cysteamine treatment.
Shimatsu A; Kato Y; Matsushita N; Ohta H; Kabayama Y; Imura H
Neurosci Lett; 1983 Jun; 37(3):285-9. PubMed ID: 6136940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
